PET imaging of 11 C-labeled thiamine tetrahydrofurfuryl disulfide, vitamin B 1 derivative: First-in-human study

Vitamine B thiamine is an essential component for glucose metabolism and energy production. The disulfide derivative, thiamine tetrahydrofurfuryl disulfide (TTFD), is more absorbent compared to readily-available water-soluble thiamine salts since it does not require the rate-limiting transport syste...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2021-05, Vol.555, p.7
Hauptverfasser: Watanabe, Yasuyoshi, Mawatari, Aya, Aita, Kazuki, Sato, Yuzuru, Wada, Yasuhiro, Nakaoka, Takayoshi, Onoe, Kayo, Yamano, Emi, Akamatsu, Go, Ohnishi, Akihito, Shimizu, Keiji, Sasaki, Masahiro, Doi, Hisashi, Senda, Michio
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 7
container_title Biochemical and biophysical research communications
container_volume 555
creator Watanabe, Yasuyoshi
Mawatari, Aya
Aita, Kazuki
Sato, Yuzuru
Wada, Yasuhiro
Nakaoka, Takayoshi
Onoe, Kayo
Yamano, Emi
Akamatsu, Go
Ohnishi, Akihito
Shimizu, Keiji
Sasaki, Masahiro
Doi, Hisashi
Senda, Michio
description Vitamine B thiamine is an essential component for glucose metabolism and energy production. The disulfide derivative, thiamine tetrahydrofurfuryl disulfide (TTFD), is more absorbent compared to readily-available water-soluble thiamine salts since it does not require the rate-limiting transport system required for thiamine absorption. However, the detailed pharmacokinetics of thiamine and TTFD under normal and pathological conditions were not clarified yet. Recently, C-labeled thiamine and TTFD were synthesized by our group, and their pharmacokinetics were investigated by PET imaging in normal rats. In this study, to clarify the whole body pharmacokinetics of [ C]TTFD in human healthy volunteers, we performed first-in-human PET imaging study with [ C]TTFD, along with radiation dosimetry of [ C]TTFD in humans. Synthesis of [ C]TTFD was improved for clinical study. Dynamic whole-body PET images were acquired on three young male normal subjects after intravenous injection of [ C]TTFD. VOIs were defined for source organs on the PET images to measure time-course of [ C]TTFD uptake as percentage injected dose and the number of disintegrations for each organ. Radiation dosimetry was calculated with OLINDA/EXM. We succeeded in developing the improved synthetic method of [ C]TTFD for the first-in-human PET study. In the whole body imaging, uptake of [ C]TTFD by various tissues was almost plateaued at 10 min after intravenous injection, afterward gradually increased for the brain and urinary bladder (urine). %Injected dose was high in the liver, kidney, urinary bladder, heart, spine, brain, spleen, pancreas, stomach, and salivary glands, in this order. %Injected dose per gram of tissue was high also in the pituitary. By dosimetry, the effective radiation dose of [ C]TTFD calculated was 5.5 μSv/MBq (range 5.2-5.7). Novel synthetic method enabled clinical PET study with [ C]TTFD, which is a safe PET tracer with a dosimetry profile comparable to other common C-PET tracers. Pharmacokinetics of TTFD in the pharmacological dose and at different nutritional states could be further investigated by future quantitative PET studies. Noninvasive in vivo PET imaging for pathophysiology of thiamine-related function may provide diagnostic evidence of novel information about vitamin B deficiency in human tissues.
doi_str_mv 10.1016/j.bbrc.2021.03.119
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_33812058</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>33812058</sourcerecordid><originalsourceid>FETCH-pubmed_primary_338120583</originalsourceid><addsrcrecordid>eNqFjk1Lw0AQQBdBbLX-AQ8yP8BdZ5JaGo-WFo8eei-b7qSZsknKfgTy762gZ-HBu7zDU-qJ0BDS6vVs6jocTYEFGSwNUXWj5oQV6oJwOVP3MZ4RiZar6k7NynJNBb6t52r42u5BOnuS_gRDA0Sw0d7W7NlBasV20jMkTsG2kwtDk8OVyYOTmH0jjl9glPSTwQcQOA4y2iQjv8NOQkxaet3mzvYQU3bTQt021kd-_PWDet5t95tPfcl1x-5wCdeZMB3-Dst_g2-wZ0ze</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>PET imaging of 11 C-labeled thiamine tetrahydrofurfuryl disulfide, vitamin B 1 derivative: First-in-human study</title><source>Elsevier ScienceDirect Journals</source><creator>Watanabe, Yasuyoshi ; Mawatari, Aya ; Aita, Kazuki ; Sato, Yuzuru ; Wada, Yasuhiro ; Nakaoka, Takayoshi ; Onoe, Kayo ; Yamano, Emi ; Akamatsu, Go ; Ohnishi, Akihito ; Shimizu, Keiji ; Sasaki, Masahiro ; Doi, Hisashi ; Senda, Michio</creator><creatorcontrib>Watanabe, Yasuyoshi ; Mawatari, Aya ; Aita, Kazuki ; Sato, Yuzuru ; Wada, Yasuhiro ; Nakaoka, Takayoshi ; Onoe, Kayo ; Yamano, Emi ; Akamatsu, Go ; Ohnishi, Akihito ; Shimizu, Keiji ; Sasaki, Masahiro ; Doi, Hisashi ; Senda, Michio</creatorcontrib><description>Vitamine B thiamine is an essential component for glucose metabolism and energy production. The disulfide derivative, thiamine tetrahydrofurfuryl disulfide (TTFD), is more absorbent compared to readily-available water-soluble thiamine salts since it does not require the rate-limiting transport system required for thiamine absorption. However, the detailed pharmacokinetics of thiamine and TTFD under normal and pathological conditions were not clarified yet. Recently, C-labeled thiamine and TTFD were synthesized by our group, and their pharmacokinetics were investigated by PET imaging in normal rats. In this study, to clarify the whole body pharmacokinetics of [ C]TTFD in human healthy volunteers, we performed first-in-human PET imaging study with [ C]TTFD, along with radiation dosimetry of [ C]TTFD in humans. Synthesis of [ C]TTFD was improved for clinical study. Dynamic whole-body PET images were acquired on three young male normal subjects after intravenous injection of [ C]TTFD. VOIs were defined for source organs on the PET images to measure time-course of [ C]TTFD uptake as percentage injected dose and the number of disintegrations for each organ. Radiation dosimetry was calculated with OLINDA/EXM. We succeeded in developing the improved synthetic method of [ C]TTFD for the first-in-human PET study. In the whole body imaging, uptake of [ C]TTFD by various tissues was almost plateaued at 10 min after intravenous injection, afterward gradually increased for the brain and urinary bladder (urine). %Injected dose was high in the liver, kidney, urinary bladder, heart, spine, brain, spleen, pancreas, stomach, and salivary glands, in this order. %Injected dose per gram of tissue was high also in the pituitary. By dosimetry, the effective radiation dose of [ C]TTFD calculated was 5.5 μSv/MBq (range 5.2-5.7). Novel synthetic method enabled clinical PET study with [ C]TTFD, which is a safe PET tracer with a dosimetry profile comparable to other common C-PET tracers. Pharmacokinetics of TTFD in the pharmacological dose and at different nutritional states could be further investigated by future quantitative PET studies. Noninvasive in vivo PET imaging for pathophysiology of thiamine-related function may provide diagnostic evidence of novel information about vitamin B deficiency in human tissues.</description><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2021.03.119</identifier><identifier>PMID: 33812058</identifier><language>eng</language><publisher>United States</publisher><ispartof>Biochemical and biophysical research communications, 2021-05, Vol.555, p.7</ispartof><rights>Copyright © 2021 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33812058$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watanabe, Yasuyoshi</creatorcontrib><creatorcontrib>Mawatari, Aya</creatorcontrib><creatorcontrib>Aita, Kazuki</creatorcontrib><creatorcontrib>Sato, Yuzuru</creatorcontrib><creatorcontrib>Wada, Yasuhiro</creatorcontrib><creatorcontrib>Nakaoka, Takayoshi</creatorcontrib><creatorcontrib>Onoe, Kayo</creatorcontrib><creatorcontrib>Yamano, Emi</creatorcontrib><creatorcontrib>Akamatsu, Go</creatorcontrib><creatorcontrib>Ohnishi, Akihito</creatorcontrib><creatorcontrib>Shimizu, Keiji</creatorcontrib><creatorcontrib>Sasaki, Masahiro</creatorcontrib><creatorcontrib>Doi, Hisashi</creatorcontrib><creatorcontrib>Senda, Michio</creatorcontrib><title>PET imaging of 11 C-labeled thiamine tetrahydrofurfuryl disulfide, vitamin B 1 derivative: First-in-human study</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>Vitamine B thiamine is an essential component for glucose metabolism and energy production. The disulfide derivative, thiamine tetrahydrofurfuryl disulfide (TTFD), is more absorbent compared to readily-available water-soluble thiamine salts since it does not require the rate-limiting transport system required for thiamine absorption. However, the detailed pharmacokinetics of thiamine and TTFD under normal and pathological conditions were not clarified yet. Recently, C-labeled thiamine and TTFD were synthesized by our group, and their pharmacokinetics were investigated by PET imaging in normal rats. In this study, to clarify the whole body pharmacokinetics of [ C]TTFD in human healthy volunteers, we performed first-in-human PET imaging study with [ C]TTFD, along with radiation dosimetry of [ C]TTFD in humans. Synthesis of [ C]TTFD was improved for clinical study. Dynamic whole-body PET images were acquired on three young male normal subjects after intravenous injection of [ C]TTFD. VOIs were defined for source organs on the PET images to measure time-course of [ C]TTFD uptake as percentage injected dose and the number of disintegrations for each organ. Radiation dosimetry was calculated with OLINDA/EXM. We succeeded in developing the improved synthetic method of [ C]TTFD for the first-in-human PET study. In the whole body imaging, uptake of [ C]TTFD by various tissues was almost plateaued at 10 min after intravenous injection, afterward gradually increased for the brain and urinary bladder (urine). %Injected dose was high in the liver, kidney, urinary bladder, heart, spine, brain, spleen, pancreas, stomach, and salivary glands, in this order. %Injected dose per gram of tissue was high also in the pituitary. By dosimetry, the effective radiation dose of [ C]TTFD calculated was 5.5 μSv/MBq (range 5.2-5.7). Novel synthetic method enabled clinical PET study with [ C]TTFD, which is a safe PET tracer with a dosimetry profile comparable to other common C-PET tracers. Pharmacokinetics of TTFD in the pharmacological dose and at different nutritional states could be further investigated by future quantitative PET studies. Noninvasive in vivo PET imaging for pathophysiology of thiamine-related function may provide diagnostic evidence of novel information about vitamin B deficiency in human tissues.</description><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFjk1Lw0AQQBdBbLX-AQ8yP8BdZ5JaGo-WFo8eei-b7qSZsknKfgTy762gZ-HBu7zDU-qJ0BDS6vVs6jocTYEFGSwNUXWj5oQV6oJwOVP3MZ4RiZar6k7NynJNBb6t52r42u5BOnuS_gRDA0Sw0d7W7NlBasV20jMkTsG2kwtDk8OVyYOTmH0jjl9glPSTwQcQOA4y2iQjv8NOQkxaet3mzvYQU3bTQt021kd-_PWDet5t95tPfcl1x-5wCdeZMB3-Dst_g2-wZ0ze</recordid><startdate>20210528</startdate><enddate>20210528</enddate><creator>Watanabe, Yasuyoshi</creator><creator>Mawatari, Aya</creator><creator>Aita, Kazuki</creator><creator>Sato, Yuzuru</creator><creator>Wada, Yasuhiro</creator><creator>Nakaoka, Takayoshi</creator><creator>Onoe, Kayo</creator><creator>Yamano, Emi</creator><creator>Akamatsu, Go</creator><creator>Ohnishi, Akihito</creator><creator>Shimizu, Keiji</creator><creator>Sasaki, Masahiro</creator><creator>Doi, Hisashi</creator><creator>Senda, Michio</creator><scope>NPM</scope></search><sort><creationdate>20210528</creationdate><title>PET imaging of 11 C-labeled thiamine tetrahydrofurfuryl disulfide, vitamin B 1 derivative: First-in-human study</title><author>Watanabe, Yasuyoshi ; Mawatari, Aya ; Aita, Kazuki ; Sato, Yuzuru ; Wada, Yasuhiro ; Nakaoka, Takayoshi ; Onoe, Kayo ; Yamano, Emi ; Akamatsu, Go ; Ohnishi, Akihito ; Shimizu, Keiji ; Sasaki, Masahiro ; Doi, Hisashi ; Senda, Michio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_338120583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watanabe, Yasuyoshi</creatorcontrib><creatorcontrib>Mawatari, Aya</creatorcontrib><creatorcontrib>Aita, Kazuki</creatorcontrib><creatorcontrib>Sato, Yuzuru</creatorcontrib><creatorcontrib>Wada, Yasuhiro</creatorcontrib><creatorcontrib>Nakaoka, Takayoshi</creatorcontrib><creatorcontrib>Onoe, Kayo</creatorcontrib><creatorcontrib>Yamano, Emi</creatorcontrib><creatorcontrib>Akamatsu, Go</creatorcontrib><creatorcontrib>Ohnishi, Akihito</creatorcontrib><creatorcontrib>Shimizu, Keiji</creatorcontrib><creatorcontrib>Sasaki, Masahiro</creatorcontrib><creatorcontrib>Doi, Hisashi</creatorcontrib><creatorcontrib>Senda, Michio</creatorcontrib><collection>PubMed</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watanabe, Yasuyoshi</au><au>Mawatari, Aya</au><au>Aita, Kazuki</au><au>Sato, Yuzuru</au><au>Wada, Yasuhiro</au><au>Nakaoka, Takayoshi</au><au>Onoe, Kayo</au><au>Yamano, Emi</au><au>Akamatsu, Go</au><au>Ohnishi, Akihito</au><au>Shimizu, Keiji</au><au>Sasaki, Masahiro</au><au>Doi, Hisashi</au><au>Senda, Michio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PET imaging of 11 C-labeled thiamine tetrahydrofurfuryl disulfide, vitamin B 1 derivative: First-in-human study</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2021-05-28</date><risdate>2021</risdate><volume>555</volume><spage>7</spage><pages>7-</pages><eissn>1090-2104</eissn><abstract>Vitamine B thiamine is an essential component for glucose metabolism and energy production. The disulfide derivative, thiamine tetrahydrofurfuryl disulfide (TTFD), is more absorbent compared to readily-available water-soluble thiamine salts since it does not require the rate-limiting transport system required for thiamine absorption. However, the detailed pharmacokinetics of thiamine and TTFD under normal and pathological conditions were not clarified yet. Recently, C-labeled thiamine and TTFD were synthesized by our group, and their pharmacokinetics were investigated by PET imaging in normal rats. In this study, to clarify the whole body pharmacokinetics of [ C]TTFD in human healthy volunteers, we performed first-in-human PET imaging study with [ C]TTFD, along with radiation dosimetry of [ C]TTFD in humans. Synthesis of [ C]TTFD was improved for clinical study. Dynamic whole-body PET images were acquired on three young male normal subjects after intravenous injection of [ C]TTFD. VOIs were defined for source organs on the PET images to measure time-course of [ C]TTFD uptake as percentage injected dose and the number of disintegrations for each organ. Radiation dosimetry was calculated with OLINDA/EXM. We succeeded in developing the improved synthetic method of [ C]TTFD for the first-in-human PET study. In the whole body imaging, uptake of [ C]TTFD by various tissues was almost plateaued at 10 min after intravenous injection, afterward gradually increased for the brain and urinary bladder (urine). %Injected dose was high in the liver, kidney, urinary bladder, heart, spine, brain, spleen, pancreas, stomach, and salivary glands, in this order. %Injected dose per gram of tissue was high also in the pituitary. By dosimetry, the effective radiation dose of [ C]TTFD calculated was 5.5 μSv/MBq (range 5.2-5.7). Novel synthetic method enabled clinical PET study with [ C]TTFD, which is a safe PET tracer with a dosimetry profile comparable to other common C-PET tracers. Pharmacokinetics of TTFD in the pharmacological dose and at different nutritional states could be further investigated by future quantitative PET studies. Noninvasive in vivo PET imaging for pathophysiology of thiamine-related function may provide diagnostic evidence of novel information about vitamin B deficiency in human tissues.</abstract><cop>United States</cop><pmid>33812058</pmid><doi>10.1016/j.bbrc.2021.03.119</doi></addata></record>
fulltext fulltext
identifier EISSN: 1090-2104
ispartof Biochemical and biophysical research communications, 2021-05, Vol.555, p.7
issn 1090-2104
language eng
recordid cdi_pubmed_primary_33812058
source Elsevier ScienceDirect Journals
title PET imaging of 11 C-labeled thiamine tetrahydrofurfuryl disulfide, vitamin B 1 derivative: First-in-human study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T03%3A02%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PET%20imaging%20of%2011%20C-labeled%20thiamine%20tetrahydrofurfuryl%20disulfide,%20vitamin%20B%201%20derivative:%20First-in-human%20study&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Watanabe,%20Yasuyoshi&rft.date=2021-05-28&rft.volume=555&rft.spage=7&rft.pages=7-&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2021.03.119&rft_dat=%3Cpubmed%3E33812058%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/33812058&rfr_iscdi=true